Clinical Trial Update: BBBD Followed By Methotrexate and Carboplatin With or Without Trastuzumab in Treating Women With Breast Cancer That Has Spread to the Brain [Phase 1, Phase 2]

View source ↗

Summary

This trial evaluating BBBD followed by methotrexate and carboplatin with or without trastuzumab for breast cancer with brain metastases has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Brain Metastases
• Breast Cancer with Brain Metastases

Drugs mentioned

• CARBOPLATIN (Carboplatin)
• HERCEPTIN (trastuzumab)
• METHOTREXATE (METHOTREXATE)

Snippet

Sponsor: OHSU Knight Cancer Institute | Conditions: Brain and Central Nervous System Tumors, Breast Cancer | Phase 1, Phase 2 | Status: WITHDRAWN